Terms: = Lymphoma AND NCOA4, RP11-481A12_4, 8031, ENSG00000138293, PTC3, ELE1, Q13772, RFG, DKFZp762E1112, ARA70
46874 results:
1. Examining the relationship between land use and childhood leukemia and lymphoma in Tehran.
Norzaee S; Yunesian M; Ghorbanian A; Farzadkia M; Rezaei Kalantary R; Kermani M; Nourbakhsh SM; Eghbali A
Sci Rep; 2024 May; 14(1):12417. PubMed ID: 38816573
[TBL] [Abstract] [Full Text] [Related]
2. Risk of second primary thyroid cancer in cancer survivors.
Yuan Y; Sun P; Xiao H; Li L; Li J; Ai X
Sci Rep; 2024 May; 14(1):12478. PubMed ID: 38816510
[TBL] [Abstract] [Full Text] [Related]
3. IL-15 gene mutation as a molecular risk factor in acute lymphoid leukemia.
Mohammed SI; Hassan KM; Azeez DM; Qadir FA; Salihi AB
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):10-17. PubMed ID: 38814240
[TBL] [Abstract] [Full Text] [Related]
4. [Effect of Shoutai Pills on expression of key glycolytic proteins and apoptosis related factors at maternal fetal interface in mouse model of threatened abortion with syndrome of kidney deficiency].
Song YJ; Li DD; Lyu JF; Jiang M; DU HL
Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2169-2177. PubMed ID: 38812232
[TBL] [Abstract] [Full Text] [Related]
5. Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma.
Bender B; Li CC; Marchand M; Turner DC; Li F; Vadhavkar S; Wang B; Deng R; Lu J; Jin J; Li C; Yin S; Wei M; Chanu P
Clin Transl Sci; 2024 Jun; 17(6):e13825. PubMed ID: 38808543
[TBL] [Abstract] [Full Text] [Related]
6. 18F-FDG PET/MR for diagnosis of primary central nervous system lymphoma: protocol for a systematic review and meta-analysis.
Qiu X; Zheng H; Zhong F; Shen B
BMJ Open; 2024 May; 14(5):e081458. PubMed ID: 38806425
[TBL] [Abstract] [Full Text] [Related]
7. Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndromes.
Kadia TM; Huang M; Pemmaraju N; Abbas HA; Ly C; Masarova L; Yilmaz M; Lyu MA; Zeng K; Sadeghi T; Cook R; DiNardo CD; Daver N; Issa GC; Jabbour E; Borthakur G; Jain N; Garcia-Manero G; Parmar S; Flowers C; Kantarjian H; Verstovsek S
NEJM Evid; 2024 Jun; 3(6):EVIDoa2300362. PubMed ID: 38804782
[TBL] [Abstract] [Full Text] [Related]
8. Predictive Factors of Therapy-Related Cardiovascular Events in Patients with lymphoma Receiving Anthracyclines.
Lopez-Garcia A; Macia E; Gomez-Talavera S; Castillo E; Morillo D; Tuñon J; Ibañez B; Cordoba R
Med Sci (Basel); 2024 Apr; 12(2):. PubMed ID: 38804379
[TBL] [Abstract] [Full Text] [Related]
9. [Activated phosphoinositide 3-kinase delta syndrome: report of seven cases].
Liu QH; Peng L; Huang H; Deng LJ; Zhong LL
Zhongguo Dang Dai Er Ke Za Zhi; 2024 May; 26(5):499-505. PubMed ID: 38802911
[TBL] [Abstract] [Full Text] [Related]
10. Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China.
Yu W; Huang L; Mei H; Li Y; Niu T; Zou D; Liu Y; Zhang H; Liu P; Wu J; Wang Z; Li H; Cai Q; Mi JQ
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38802271
[TBL] [Abstract] [Full Text] [Related]
11. General anaesthetics reduce acute lymphoblastic leukaemia malignancies
Jiang C; Gonzalez-Anton S; Li X; Mi E; Wu L; Zhao H; Zhang G; Lu A; Lo Celso C; Ma D
F1000Res; 2022; 11():1491. PubMed ID: 38798305
[TBL] [Abstract] [Full Text] [Related]
12. Regulation of the
Gu P; Huang W; Lu W; Shu P
Discov Med; 2024 May; 36(184):923-935. PubMed ID: 38798252
[TBL] [Abstract] [Full Text] [Related]
13. Paradoxical Psoriasis.
Abdelghaffar M; Kottilil S; Murphy MJ; Cohen JM; Damsky W
Dermatol Clin; 2024 Jul; 42(3):471-480. PubMed ID: 38796276
[TBL] [Abstract] [Full Text] [Related]
14. Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.
Dupuis J; Bachy E; Morschhauser F; Cartron G; Fukuhara N; Daguindau N; Casasnovas RO; Snauwaert S; Gressin R; Fox CP; d'Amore FA; Staber PB; Tournilhac O; Bouabdallah K; Thieblemont C; André M; Rai S; Ennishi D; Gkasiamis A; Nishio M; Fornecker LM; Delfau-Larue MH; Sako N; Mule S; de Leval L; Gaulard P; Tsukasaki K; Lemonnier F
Lancet Haematol; 2024 Jun; 11(6):e406-e414. PubMed ID: 38796193
[TBL] [Abstract] [Full Text] [Related]
15. A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.
Kilickap S; Ozturk A; Karadurmus N; Korkmaz T; Yumuk PF; Cicin I; Paydas S; Cilbir E; Sakalar T; Uysal M; Yesil Cinkir H; Uskent N; Demir N; Sakin A; Dursun OU; Aver B; Turhal NS; Keskin S; Tural D; Eralp Y; Bugdayci Basal F; Yasar HA; Sendur MAN; Demirci U; Cubukcu E; Karaagac M; Cakar B; Tatli AM; Yetisyigit T; Urvay S; Gursoy P; Oyan B; Turna ZH; Isikdogan A; Olmez OF; Yazici O; Cabuk D; Seker MM; Unal OU; Meydan N; Okutur SK; Tunali D; Erman M;
Medicine (Baltimore); 2024 May; 103(21):e37972. PubMed ID: 38787994
[TBL] [Abstract] [Full Text] [Related]
16. Brentuximab Vedotin Retreatment in Patients with Relapsed or Refractory Classical Hodgkin lymphoma or Peripheral T-Cell lymphoma: A Retrospective United States Claims Analysis.
Sano D; Liu N; Knowles S; MacEwan JP; Wang S; Wogen J; Yu KS; Lee ST
Curr Oncol; 2024 May; 31(5):2598-2609. PubMed ID: 38785476
[TBL] [Abstract] [Full Text] [Related]
17. The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.
Li X; Wu D; Tang J; Wu Y
J Cancer Res Clin Oncol; 2024 May; 150(5):271. PubMed ID: 38780840
[TBL] [Abstract] [Full Text] [Related]
18. CAR T-Cell Immunotherapy in Minority Patients with lymphoma.
Ghilardi G; Williamson S; Pajarillo R; Paruzzo L; Chen L; Grady C; Doucette A; Nemecek E; Gabrielli G; Barta SK; Svoboda J; Chong EA; Yelton R; Nasta SD; Landsburg DJ; Ugwuanyi O; Chen AI; Schachter L; White G; Ballard HJ; Weber E; Curley C; Porter DL; Garfall AL; Hwang WT; Guerra CE; Maziarz RT; Schuster SJ; Ruella M
NEJM Evid; 2024 Apr; 3(4):EVIDoa2300213. PubMed ID: 38776868
[TBL] [Abstract] [Full Text] [Related]
19. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
[TBL] [Abstract] [Full Text] [Related]
20. The outcome of relapsed childhood acute lymphoblastic leukemia after allogeneic hematopoietic stem-cell transplantations: A single-center experience.
Aygüneş U; Karagün BŞ; Şaşmaz I; Antmen AB
Clin Transplant; 2024 May; 38(5):e15366. PubMed ID: 38775798
[TBL] [Abstract] [Full Text] [Related]
[Next]
